Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
|HEADQUARTERS||531 South Spring Street
Burlington, North Carolina 27215
|NUMBER OF EMPLOYEES||Over 70,000 worldwide|
|ANNUAL REVENUE||$11.5 Billion (2019)|
|CHIEF EXECUTIVE OFFICER||Adam H. Schechter|
|PATIENT ACCESS POINTS||Labcorp provides patient access points, strategically and conveniently located throughout the U.S., including nearly 2,000 PSCs and more than 6,000 in-office phlebotomists who are located in customer offices and facilities.|
|LABCORP SPECIALTY TESTING||
Labcorp offers a comprehensive menu of frequently requested and specialty tests through an integrated network of primary and specialty laboratories across the United States. The company provides a range of specialty testing services in the areas of women’s health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring. Labcorp’s Specialty Testing Group performs esoteric testing, cancer diagnostics and other complex procedures.
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and save lives. With over 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $11.5 billion in FY2019. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.
|CONTACT PERSON||Christopher Allman-Bradshaw
Director, Media Relations and PR
Access the LabCorp corporate backgrounder.